MEDIA RELEASE PR41141
Liquent Announces New Solution Strategies Following Merger with Datafarm
HORSHAM, Pa., Sept. 9 /PRNewswire-AsiaNet/ --
Updated and New Solutions align with Liquent Vision and Mission
Liquent Inc., the global leader in regulatory information management solutions and services, revealed today its
new solution branding positioning. The announcement comes approximately three months following the merger of
the Liquent and Datafarm organizations announced June 1, 2010.
"The combined strengths of Liquent and Datafarm offers the new Liquent
greater opportunities to serve our clients and the Life Sciences market
place," said Rick Riegel, CEO of Liquent. "We are excited to provide the
industry with an informative first look at our strategic direction and share
a number of exciting new products that represent a new chapter in Liquent's
long history of innovation. Our new solutions were developed to support the
market demands of Tier1, Tier2 and Tier3 Life Sciences organizations."
"Liquent hosted a series of web conferences with its client community in
August and the feedback has been wholly positive," adds Jim Nichols,
Liquent's Vice President, Strategy. "In times of exciting change like this
merger, we are adamant about clearly articulating our plans to our clients
and the market."
In the web conferences, Liquent unveiled its new combined solution
portfolio and its branding. Liquent InSight(R) will be repositioned with
three core focus areas: Liquent InSight for Registrations, Liquent InSight
for Submissions and Liquent InSight for Viewing. These software solutions are
already widely used in the industry and the new positioning will better
enable Liquent's clients to adopt the technology into their organizations.
Liquent's regulatory operations outsourcing offerings will be rebranded as
Liquent Direct(R) and also offer three core focus areas: regulatory affairs,
regulatory operations and medical writing.
Liquent's latest products and services will be showcased at its upcoming
European conference, Liquent Horizons, scheduled to be held in Paris, France
on September 13-15, 2010. In addition to its product test lab, the conference
will also offer presentations provided by industry experts and is expected to
have its highest attendance levels ever in its history.
ABOUT LIQUENT
Liquent regulatory solutions provide software and related regulatory and
clinical services for the life sciences industry. These solutions and
services help ensure clients meet the strict standards of regulatory
authorities across the world helping them achieve quality, accuracy, and data
integrity to deliver regulatory reports and submissions reliably and on time.
Liquent is owned by Marlin Equity Partners.
About Marlin Equity Partners
Marlin Equity Partners is a Los Angeles, California-based private
investment firm with over US$1 billion of capital under management. The firm
is focused on providing corporate parents, shareholders and other
stakeholders with tailored solutions that meet their business and liquidity
needs. Marlin invests in businesses across multiple industries that are in
the process of undergoing varying degrees of operational, financial or
market-driven change where its capital base, industry relationships and
extensive network of operational resources significantly strengthens a
company's outlook and enhances value. Since its inception, Marlin, through
its group of funds and related companies, has successfully completed over 35
CONTACT: Jim Nichols, Vice President, Strategy, +1-215-328-4320
SOURCE: Liquent Inc.
CONTACT: Jim Nichols, Vice President, Strategy, +1-215-328-4320
NEWS 
